Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)

Market Cap	69.44B
Revenue (ttm)	1.80B
Net Income (ttm)	-333.84M
Shares Out	1.27B
EPS (ttm)	-0.26
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,127,411
Average Volume	3,009,168
Open	54.65
Previous Close	54.89
Day's Range	54.51 - 54.87
52-Week Range	54.24 - 80.00
Beta	1.36
RSI	43.41
Earnings Date	Oct 30, 2025

About SHA:603392

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, and sells in vitro diagnostic reagents and instruments, and vaccines in China and internationally. It operates through Diagnostics Division and Vaccine Division segments. The company offers chemiluminescence detection, biochemical, hepatitis B core antibody detection, and HIV reagents; rapid urine tests for hepatitis E antigen; chronic disease management, hepatitis E screening and prevention, women’s full life-cycle health management, smart laboratories, medic...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1991
• Employees: 3,790
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603392

Financial Performance

In 2024, SHA:603392's revenue was 2.25 billion, a decrease of -59.25% compared to the previous year's 5.51 billion. Earnings were 106.24 million, a decrease of -91.49%.